Unresectable Colorectal Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2024-09-26
Clinical Trial Update: Pembrolizumab and Autologous Dendritic Cells for the Treatment of Refractory Colorectal Cancer (CRC) [Phase 2]
A Phase 2 trial of pembrolizumab with autologous dendritic cells for refractory colorectal cancer has been withdrawn.